Higher‐energy collision‐induced dissociation for the quantification by liquid chromatography/tandem ion trap mass spectrometry of nitric oxide metabolites coming from S‐nitroso‐glutathione in an in vitro model of the intestinal barrier. (9th December 2018)

• Record Type: Journal Article
• Authors: Yu, Haiyan; Bonetti, Justine; Gaucher, Caroline; Fries, Isabelle; Vernex‐Loset, Lionel; Leroy, Pierre; Chaimbault, Patrick
• Is Part Of: Rapid communications in mass spectrometry. Volume 33:Number 1(2019)
• Page Start: 1
• Page End: 11
• Publication Date: 2018-12-09
• Subjects: Mass spectrometry -- Periodicals; 543.65
• DOI: 10.1002/rcm.8287
• Languages: English
• ISSNs: 0951-4198

Abstract

Abstract : Rationale: The potency of S ‐nitrosoglutathione (GSNO) as a nitric oxide (NO) donor to treat cardiovascular diseases (CVDs) has been highlighted in numerous studies. In order to study its bioavailability after oral administration, which represents the most convenient route for the chronic treatment of CVDs, it is essential to develop an analytical method permitting (i) the simultaneous measurement of GSNO metabolites, i.e. nitrite, S ‐nitrosothiols (RSNOs) and nitrate and (ii) to distinguish them from other sources (endogenous synthesis and diet). Methods: Exogenous GSNO was labeled with 15 N, and the GS 15 NO metabolites after conversion into the nitrite ion were derivatized with 2, 3‐diaminonaphthalene. The resulting 2, 3‐naphthotriazole was quantified by liquid chromatography/tandem ion trap mass spectrometry (LC/ITMS/MS) in multiple reaction monitoring mode after Higher‐energy Collision‐induced Dissociation (HCD). Finally, the validated method was applied to an in vitro model of the intestinal barrier (monolayer of Caco‐2 cells) to study GS 15 NO intestinal permeability. Results: A LC/ITMS/MS method based on an original transition ( m/z 171 to 156) for sodium 15 N‐nitrite, GS 15 NO and sodium 15 N‐nitrate measurements was validated, with recoveries of 100.8 ± 3.8, 98.0 ± 2.7 and 104.1 ± 3.3%, respectively. Intra‐ and inter‐day variabilities were below 13.4 and 12.6%, and the limit of quantification reached 5 nM (signal over blank = 4). The permeability of labeled GS 15 NO (10–100 μM) was evaluated by calculating its apparent permeability coefficient (Papp ). Conclusions: A quantitative LC/ITMS/MS method using HCD was developed for the first time to selectively monitor GS 15 NO metabolites. The assay allowed evaluation of GS 15 NO intestinal permeability and situated this drug candidate within the middle permeability class according to FDA guidelines. In addition, the present method has opened the perspective of a more fundamental work aiming at studying the fragmentation mechanism leading to the ion at m/z 156 in HCD tandem mass spectrometry in the presence of acetonitrile.